Marianne Brüggemann

Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.

Medtronic Spine LLC develops medical devices for invasive therapies. It designs, manufactures and markets instruments used in therapies for the restoration of spinal anatomy. The company was founded in 1994 and is headquartered in Minneapolis, MN.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

ATN Holdings, Inc. manufactures and distributes ready-to-eat cereals and snacks. It offers the following brands: Peace Cereal, Erewhon, Attune, Golden Temple, Willamette Valley, Uncle Sam, and Sweet Home Farm. The company was founded by Robert Hurlbut and Kathy Oneto in November 2006 and is headquartered in Eugene, OR.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

EW Healthcare Partners Fund seeks investment opportunities in middle market companies located in the United States, Europe, Latin America, and China with revenues of USD 20 to USD 200 million. It targets companies operating in the fields of pharmaceuticals, medical devices, healthcare services, and healthcare IT. It provides financing for growth capital requirements with an investment size ranging from USD 20 to USD 80 million and invest up to USD 100 million. It also acquires minority and majority interest.

GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA.

Part of Graham Holdings Co., THP Ltd is a British company that provides structural and architectural engineering services. The company was founded by Roland Buelow. THP was acquired by Tribeca Learning Pty Ltd., part of Graham Holdings Co. from May 26, 2006 on March 29, 2001.

ODC Therapy, Inc. operates offices of physical, occupational and speech therapists and audiologists. The company develops, produces and distributes customized cancer vaccines to individual patients and then monitors their immune response after treatment. The company was founded in 2004 and is headquartered in Dallas, TX.

Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA.

Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA.

The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015.

Medical, Inc. wholesales and repairs medical equipment. The non-profit company is based in Decatur, AL.

The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation.

TeneoBio, Inc. operates as a biotechnology company that develops biologics, human heavy chain antibodies, as therapeutics against cancer, autoimmunity, and infectious diseases. Its products provides treatment of multiple myeloma, prostate cancer, immune disorders, and AIDS. The company was founded by Roland Buelow, on August 9, 2009 and is headquartered in Menlo Park, CA.

Medikine, Inc. is a privately held biopharmaceutical company located in an undisclosed location. The American company's mission is to transform the discovery of oncology, autoimmune disorder, and infectious disease therapeutics by employing a versatile drug discovery platform that generates modular "peptikines." These peptikines are peptide mimetics of cytokines that are smaller in molecular size than, and structurally unrelated to, the natural cytokines they emulate. Medikine's lead candidate, mdk-703, is currently in a phase 1 clinical trial in healthy volunteers. Ronald W. Barrett has been the CEO of the company since 2016.

Part of AbbVie, Inc., TeneoOne, Inc. develops innovative medicines. The CEO of the American company is Roland Buelow.

Ancora Biotech LLC is a privately held service provider that supports the clinical development of assets for TeneoTwo, TeneoFour, and TeneoTen, which are all part of TBIO, LLC. The company is based in Palo Alto, CA. Ancora oversees the manufacturing and clinical development of these assets, including TeneoTwo's clinical stage TNB-486, TeneoFour's preclinical TNB-738, and TeneoTen's development of preclinical anti-HBVxCD3 for the treatment of chronic hepatitis B. The company was founded by Roland Buelow.